NICE: Q4 Earnings Insights NICE (NASDAQ:NICE) reported its Q4 earnings results on Thursday, February 17, 2022 at 05:30 AM. Here's what investors need to know about the announcement. Benzinga · Feb 17, 2022
NICE Tops Q4 Backed By Cloud Momentum NICE Ltd (NASDAQ:NICE) reported fourth-quarter FY21 non-GAAP revenue growth of 17.6% year on year to $515.5 million, beating the consensus of $496.1 million. Non-GAAP revenues from Cloud grew 28.1% Y/Y to $285 million. Non-GAAP gross margin expanded 80 bps to 73%, while the non-GAAP operating margin contracted 190 bps to 28.2%. Non-GAAP EPS… Benzinga · Feb 17, 2022
Tanguy Ndombele's verdict on his start to life back at Lyon as Tottenham loanee impresses coach Tanguy Ndombele recorded an assist at the weekend for Lyon in their win over Nice as the Tottenham Hotspur midfielder continues to enjoy his football on his return to France Football London · Feb 16, 2022
The NHS is now recommending revolutionary drug for obesity treatment The drug suppresses appetite by mimicking a hormone that is released after eating The Independent UK · Feb 9, 2022
NICE approves revolutionary drug for obesity treatment The drug suppresses appetite by mimicking a hormone that is released after eating The Independent UK · Feb 8, 2022
Thousands of obese people to get fat-busting drug on the NHS In some cases, those with a BMI of 30 may be able to access semaglutide, which is given via a pen injector. The Independent UK · Feb 8, 2022